Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne M Murray

Showing results (111-120 of 144) with videos related to

Pageof 15
Sort By:
Public Health Reports (Washington, D.C. : 1974)|January 21, 2022
Minnesota Electronic Health Record Consortium COVID-19 Project: Informing Pandemic Response Through Statewide Collaboration Using Observational DataTyler N A Winkelman, Karen L Margolis, Stephen Waring, et al.
JAMA Network Open|July 26, 2023
Low-Dose Aspirin and the Risk of Stroke and Intracerebral Bleeding in Healthy Older People: Secondary Analysis of a Randomized Clinical TrialGeoffrey C Cloud, Jeff D Williamson, Le Thi Phuong Thao, et al.
Age and Ageing|April 25, 2023
Prediabetes, diabetes and loss of disability-free survival in a community-based older cohort: a post-hoc analysis of the ASPirin in Reducing Events in the Elderly trialZhen Zhou, Andrea J Curtis, Alice Owen, et al.
European Journal of Preventive Cardiology|June 6, 2025
Stratification by CVD risk equations does not inform the use of aspirin for primary prevention in older adultsEnayet K Chowdhury, Michael E Ernst, Mark R Nelson, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 9, 2016
The Brain in Kidney Disease (BRINK) Cohort Study: Design and Baseline Cognitive FunctionAnne M Murray, Elizabeth J Bell, David E Tupper, et al.
The Lancet. Healthy Longevity|February 28, 2022
A multistate model of health transitions in older people: a secondary analysis of ASPREE clinical trial dataJohannes T Neumann, Le T P Thao, Emily Callander, et al.
JAMA Internal Medicine|February 5, 2014
Cognitive function and brain structure in persons with type 2 diabetes mellitus after intensive lowering of blood pressure and lipid levels: a randomized clinical trialJeff D Williamson, Lenore J Launer, R Nick Bryan, et al.
JAMA Oncology|September 25, 2025
Low-Dose Aspirin for Individualized Cancer Prevention in Older Adults: A Secondary Analysis of the ASPREE Randomized Clinical TrialLe Thi Phuong Thao, Tri-Long Nguyen, Jasmine Singh, et al.
Geroscience|January 12, 2026
Association between cardiovascular-kidney-metabolic syndrome and risks of 14 age-related health outcomes in primary prevention older populationZhen Zhou, Kevan R Polkinghorne, Andrew M Tonkin, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|October 3, 2022
Combination of gait speed and grip strength to predict cognitive decline and dementiaSuzanne G Orchard, Galina Polekhina, Joanne Ryan, et al.
Pageof 15

Showing results (111-120 of 144) with videos related to

Sort By:
Pageof 15
Public Health Reports (Washington, D.C. : 1974)|January 21, 2022
Minnesota Electronic Health Record Consortium COVID-19 Project: Informing Pandemic Response Through Statewide Collaboration Using Observational DataTyler N A Winkelman, Karen L Margolis, Stephen Waring, et al.
JAMA Network Open|July 26, 2023
Low-Dose Aspirin and the Risk of Stroke and Intracerebral Bleeding in Healthy Older People: Secondary Analysis of a Randomized Clinical TrialGeoffrey C Cloud, Jeff D Williamson, Le Thi Phuong Thao, et al.
Age and Ageing|April 25, 2023
Prediabetes, diabetes and loss of disability-free survival in a community-based older cohort: a post-hoc analysis of the ASPirin in Reducing Events in the Elderly trialZhen Zhou, Andrea J Curtis, Alice Owen, et al.
European Journal of Preventive Cardiology|June 6, 2025
Stratification by CVD risk equations does not inform the use of aspirin for primary prevention in older adultsEnayet K Chowdhury, Michael E Ernst, Mark R Nelson, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 9, 2016
The Brain in Kidney Disease (BRINK) Cohort Study: Design and Baseline Cognitive FunctionAnne M Murray, Elizabeth J Bell, David E Tupper, et al.
The Lancet. Healthy Longevity|February 28, 2022
A multistate model of health transitions in older people: a secondary analysis of ASPREE clinical trial dataJohannes T Neumann, Le T P Thao, Emily Callander, et al.
JAMA Internal Medicine|February 5, 2014
Cognitive function and brain structure in persons with type 2 diabetes mellitus after intensive lowering of blood pressure and lipid levels: a randomized clinical trialJeff D Williamson, Lenore J Launer, R Nick Bryan, et al.
JAMA Oncology|September 25, 2025
Low-Dose Aspirin for Individualized Cancer Prevention in Older Adults: A Secondary Analysis of the ASPREE Randomized Clinical TrialLe Thi Phuong Thao, Tri-Long Nguyen, Jasmine Singh, et al.
Geroscience|January 12, 2026
Association between cardiovascular-kidney-metabolic syndrome and risks of 14 age-related health outcomes in primary prevention older populationZhen Zhou, Kevan R Polkinghorne, Andrew M Tonkin, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|October 3, 2022
Combination of gait speed and grip strength to predict cognitive decline and dementiaSuzanne G Orchard, Galina Polekhina, Joanne Ryan, et al.
Pageof 15